ENZO BIOCHEM INC 4
4 · ENZO BIOCHEM INC · Filed Dec 20, 2007
Insider Transaction Report
Form 4
GOLDBERG DAVID C
VP, Corporate Development
Transactions
- Conversion
Common Stock, par value $0.01 per share
2007-12-18+1,118→ 94,391 total - Conversion
Employee Stock Option
2007-12-18−6,381→ 48,338 totalExercise: $10.97From: 1997-12-18Exp: 2007-12-18→ Common Stock, par value $0.01 per share (6,381 underlying)
Footnotes (2)
- [F1]The Reporting Person exercised a stock option to purchase 6,381 shares of Common Stock and paid the exercise price thereof by the surrender of 5,263 shares of Common Stock, for a net gain in outstanding shares of Common Stock of 1,118 shares. The stated exercise price of the stock option was $10.97.
- [F2]As of the date hereof, the Reporting Person directly beneficially owned 41,972 shares of Common Stock, 979 shares indirectly beneficially owned through the UGMA accounts of the Reporting Person's children, 3,102 shares of Common Stock in the Issuer's 401(K) Plan and 48,338 options to purchase Common Stock, par value $0.01 per share, which are currently exercisable.